New patent expiration for Bristol Myers drug REYATAZ

Annual Drug Patent Expirations for REYATAZ Reyataz is a drug marketed by Bristol Myers Squibb and is included in two NDAs. It is available from six suppliers. There are two…

The post New patent expiration for Bristol Myers drug REYATAZ appeared first on DrugPatentWatch.

Comments are closed.